Compounds > benzoxazoles
Page last updated: 2024-08-21

benzoxazoles and Experimental Neoplasms

benzoxazoles has been researched along with Experimental Neoplasms in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19901 (20.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's4 (80.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Carol, H; Gorlick, R; Houghton, PJ; Kang, MH; Keir, ST; Kolb, EA; Kurmasheva, RT; Lock, R; Lyalin, D; Maris, JM; Reynolds, CP; Smith, MA; Wu, J1
Lin, J; Xue, L; Yin, S; Zhang, C; Zhou, L1
An, Y; Jeon, R; Kang, JS; Kim, WY; Lee, E; Lee, MY; Yu, Y; Yun, J1
Abecassis, PY; Angouillant-Boniface, O; Below, P; Benard, T; Bertrand, T; Bonnevaux, H; Carry, JC; Certal, V; Chatreaux, F; Delorme, C; El-Ahmad, Y; Filoche-Rommé, B; Halley, F; Karlsson, A; Lebourg, G; Lejeune, P; Lengauer, C; Louboutin, A; Marquette, JP; Michot, N; Nicolas, JP; Pilorge, F; Rak, A; Schio, L; Thompson, F; Vade, I; Vincent, L; Virone-Oddos, A1
Burkhardt, D; Ghosh, P; Ternai, B; Whitehouse, MW1

Other Studies

5 other study(ies) available for benzoxazoles and Experimental Neoplasms

ArticleYear
Initial testing (stage 1) of the investigational mTOR kinase inhibitor MLN0128 by the pediatric preclinical testing program.
    Pediatric blood & cancer, 2014, Volume: 61, Issue:8

    Topics: Animals; Benzoxazoles; Cell Line, Tumor; Dose-Response Relationship, Drug; Mice; Neoplasm Proteins; Neoplasms, Experimental; Protein Kinase Inhibitors; Pyrimidines; TOR Serine-Threonine Kinases; Xenograft Model Antitumor Assays

2014
Design, synthesis and biological activities of novel oxazolo[4,5-g]quinazolin-2(1H)-one derivatives as EGFR inhibitors.
    European journal of medicinal chemistry, 2015, Aug-28, Volume: 101

    Topics: Animals; Antineoplastic Agents; Benzoxazoles; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Drug Design; Drug Screening Assays, Antitumor; ErbB Receptors; Humans; Mice; Mice, SCID; Neoplasms, Experimental; Quinazolines; Structure-Activity Relationship

2015
Design and synthesis of novel benzoxazole analogs as Aurora B kinase inhibitors.
    Bioorganic & medicinal chemistry letters, 2016, 07-01, Volume: 26, Issue:13

    Topics: Animals; Antineoplastic Agents; Aurora Kinase B; Benzoxazoles; Cell Proliferation; Dose-Response Relationship, Drug; Drug Design; Humans; Mice; Mice, Nude; Models, Molecular; Molecular Structure; Neoplasms, Experimental; Protein Kinase Inhibitors; Structure-Activity Relationship

2016
Discovery and optimization of new benzimidazole- and benzoxazole-pyrimidone selective PI3Kβ inhibitors for the treatment of phosphatase and TENsin homologue (PTEN)-deficient cancers.
    Journal of medicinal chemistry, 2012, May-24, Volume: 55, Issue:10

    Topics: Animals; Antineoplastic Agents; Benzimidazoles; Benzoxazoles; Cell Line, Tumor; Class I Phosphatidylinositol 3-Kinases; Crystallography, X-Ray; Fibroblasts; Humans; Isoenzymes; Macrophages; Mice; Mice, SCID; Models, Molecular; Molecular Structure; Neoplasms, Experimental; Phosphorylation; Protein Binding; Proto-Oncogene Proteins c-akt; PTEN Phosphohydrolase; Pyrimidinones; Structure-Activity Relationship; Xenograft Model Antitumor Assays

2012
Effects of 4-nitro- and 4-sulpho-7-substituted benzofurazans on nucleic acid and protein synthesis of a malignant fibrosarcoma cell line in combination with mild hyperthermia.
    Chemico-biological interactions, 1982, Volume: 42, Issue:2

    Topics: Animals; Benzoxazoles; Cell Line; DNA; Fever; Fibrosarcoma; Neoplasms, Experimental; Nucleic Acid Precursors; Protein Biosynthesis; Rats

1982